Aquigen Bio Sciences

  Ethambutol Hydrochloride is a key antitubercular agent widely used in combination therapies to treat tuberculosis. It works by inhibiting arabinosyl transferase, an enzyme necessary for the synthesis of the mycobacterial cell wall, ultimately leading to bacterial cell death. Given its critical role in treatment protocols, ensuring the purity of Ethambutol Hydrochloride is vital for drug safety and efficacy. Importance of Impurity Profiling Impurities in pharmaceutical substances can arise during manufacturing, storage, or degradation. Monitoring and controlling these impurities is crucial to meet regulatory requirements and to ensure patient safety. AquigenBio offers high-purity reference standards for Ethambutol-related impurities that help support analytical method development, validation, and routine quality control processes. Ethambutol EP Impurity A Product Name : Ethambutol EP Impurity A Molecular Formula : C₄H₁₁NO Molecular Weight : 89.1 g/mol CAS Number : 96–20–8 De...

  In the pharmaceutical industry, impurity profiling is a critical component in drug development and quality assurance. Among the numerous impurities associated with alpha-1 adrenergic receptor antagonists,  N-Methyl Tamsulosin Impurity  plays a significant role in the characterization of Tamsulosin-based formulations. What is N-Methyl Tamsulosin Impurity? N-Methyl Tamsulosin Impurity  is a structural derivative formed during the synthesis or degradation of Tamsulosin hydrochloride, a widely prescribed drug used for treating benign prostatic hyperplasia (BPH). This impurity may arise due to methylation side reactions and needs to be closely monitored to ensure the safety, efficacy, and regulatory compliance of the final drug product. Explore detailed specifications and order here: N-Methyl Tamsulosin Impurity — Aquigen Bio Why Monitoring Tamsulosin Impurities is Crucial Tamsulosin’s pharmacological precision makes it essential to maintain a high level of purity. The ...

In recent years, stringent scrutiny regarding the quality of pharmaceutical products has exposed the critical need for  advanced analytical methods  to identify and quantify impurities. Among these impurities, N-Nitroso compounds (NOCs) have gained significant attention, owing to their potential carcinogenicity even at trace levels. Regulatory agencies, including the US FDA and EMA, consistently refine their guidelines to ensure safer drug formulations for consumers. Hence, detecting N-nitroso impurities in active pharmaceutical ingredients (APIs), excipients, and drug products has become a high-priority challenge for manufacturers. Characterized by the presence of the nitroso functional group (-N=O), N-nitroso impurities can be inadvertently formed during manufacturing processes, commonly through reactions between nitrites and secondary or tertiary amines. Their detection and quantitation require sophisticated instrumentation, precise methodologies, and an in-depth understand...

In the pharmaceutical industry, the development and manufacture of Active Pharmaceutical Ingredients (APIs) require meticulous attention to quality control and impurity management. One particularly challenging class of impurities to address is the N-nitrosamines, also known as N-nitroso compounds. These impurities have garnered significant attention in recent years due to their potential carcinogenic properties, leading to increased regulatory scrutiny and the need for robust strategies to mitigate their formation during the API manufacturing process. As a leading  API impurity standard supplier in India , Aquigen Bio Sciences has extensive expertise in addressing the challenge of N-nitroso impurities. In this blog, we will explore the sources of N-nitroso impurities, discuss effective strategies for minimizing their formation, and highlight how Aquigen Bio Sciences can assist pharmaceutical companies in manufacturing APIs with low N-nitroso impurity levels. Sources of N-nitroso Im...